¡Ö²Ê³ØÅªº¬µò¤Ë´ð¤Å¤¯ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó 2009ǯÈǡפÈ
¡Öç¹´â¼è°·¤¤µ¬Ìó 2009¡×¤¬È¯´©¤µ¤ì¤Þ¤·¤¿¡£
Êѹ¹ÅÀ¤Ï
1¡¥Âè1ÈǤκîÀ®Ã´ÅöÊìÂΤ¬ÆüËÜç¹Â¡³Ø²ñç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥óºîÀ®¾®°Ñ°÷²ñ¤Ç¤¢¤Ã¤¿¤¬¡¢º£²ó¤ÏÆüËÜç¹Â¡³Ø²ñç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó²þÄû°Ñ°÷²ñ¤È¤Ê¤Ã¤¿¡£
2¡¥ºÇ¿·¤Î¥¨¥Ó¥Ç¥ó¥¹Äɲäϡ¢Âè1ÈǽÐÈǸå¤Î¿·¤·¤¤¥¨¥Ó¥Ç¥ó¥¹¤Î·ÏÅýŪ¸¡º÷¤ò¹Ô¤¤¡¢¤µ¤é¤Ë¸½ºß¤ÎÆüËܤμÂÎ×¾²¤ò´ª°Æ¤·¤Æ¿ä¾©Ê¸¤òºîÀ®¤·¤¿¡£
CQ1-1 ¡¡ç¹´â¤Î´í¸±°ø»Ò¤Ï²¿¤«¡©1. ´í¸±°ø»Ò¤òÊ£¿ôͤ¹¤ë¾ì¹ç¤Ï¡¢ç¹´â¸¡½Ð¤Î¤¿¤á¤Î¸¡ºº¤ò¹Ô¤¦¤è¤¦´«¤á¤é¤ì¤ë¡£
¥°¥ì¡¼¥ÉB
2. ç¹´ÉÆâÆýƬǴ±ÕÀ¼ðáç¡¡(IPMN)¤Ï´â¤Ø¿ÊŸ¤¹¤ë¤³¤È¤äç¹´â¤ò¹çÊ»¤¹¤ë¤³¤È¤¬¤¢¤ë¤Î¤Ç¡¢Åª³Î¤Ê¿ÇÃǤȿµ½Å¤Ê·Ð²á´Ñ»¡¤¬´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉB
ç¹´â´µ¼Ô¤Î4-8%¤Ï²È²Îò¤Ë繴⤢¤ë¡£¡ÊÂоȷ²¤ËÈæ¤Ù13ÇܤȹâΨ¡Ë
°äÅÁÀ繱ꡢ²È²À²È²
Á£¼ð¥Ý¥ê¥Ý¡¼¥·¥¹¡¢Peutz-Jeghers¾É¸õ·²¡¢familial multiple mole melanoma¾É¸õ·²¡¢²È²À
Æý¤¬¤ó¤Ê¤É¤Î
°äÅÁÀ¼À´µ¤Ç¤Ïç¹´âȯÀ¸Î¨¤¬¹â¤¤
ç¹´â´µ¼Ô¤Î´û±ýÎò¤Ç¤Ï
ÅüǢɤ¬25.9¡ó¤ÈºÇ¤âÉÑÅÙ¤¬¹â¤¤¡£
ËÜË®¤Ç¤ÏÅüÇ¢ÉÂÎò¤Î¤¢¤ë´µ¼Ô¤Ç´í¸±Î¨¤Ï1.85ÇÜ¡£¡Ê¿¤¯¤ÎÊó¹ð¤Ç¤Ï¤ª¤ª¤è¤½1.8-2.1ÇܤǤ¢¤ë¡Ë
ÈîËþ¤ä²áÂνŤÏç¹´â´í¸±Î¨¤òÁý²Ã¤µ¤»¤ë¡£BMJ30°Ê¾å¤Ç¤Ï1.8ÇÜ
ËýÀç¹±ê¤Îç¹´âȯÀ¸¤ÎÁêÂÐŪ´í¸±ÅÙ¤Ï4-8ÇÜ¡£
IPMN 0.95-1.1%/ǯ
µÊ±ì¤Ïç¹´â¤Î´í¸±Î¨¤ò2-3ÇܤËÁý²Ã¤µ¤»¤ë¡£ÃËÀ¤Ç¤Ï¶Ø±ì¤Ë¤è¤êç¹´â¤Î22¡ó¤ÏͽËɤǤ¤ë¡£
CQ1-2 ç¹´â¤ÎÎ×¾²¾É¾õ¤Ï²¿¤«¡©1. ¾¤Ë¸¶°ø¤Î¤ß¤é¤ì¤Ê¤¤Ê¢ÄË¡¢¹øÇØÉôÄË¡¢
²«áÕ¡¢ÂνŸº¾¯¤Ïç¹´â¤òµ¿¤¤¸¡ºº¤ò¹Ô¤¦¤¬¡Ê¥°¥ì¡¼¥ÉB¡Ë¡¢Í¾É¾õ¤Î¾ì¹ç¤Ï¿Ê¹Ô´â¤¬Â¿¤¤¡£¡¡
2. µÞ·ã¤ÊÅüǢɡÊÅüÂå¼Õ¾ã³²¡Ë¤Îȯ¾É¤ä°²½¤Ïç¹´â¹çÊ»¤òµ¿¤¤¡¢¸¡ºº¤ò¹Ô¤¦¡Ê¥°¥ì¡¼¥ÉB¡Ë¡£ÆÃ¤ËÅüÇ¢ÉÂȯ¾É¸å3ǯ¤ÏÃí°Õ¤òÍפ¹¤ë¡£¡¡
ƬÉô´â¤Ç¾É¾õ¤Îȯ¸½Î¨¤¬ºÇ¤â¹â¤¯¡¢²«áÕ63%, Ê¢ÄË64%,¡¡ÂνŸº¾¯53%
ÂÎÉô´â¤Ç¤ÏÊ¢Äˤ¬93¡ó¤ÈºÇ¤â¹â¤¤¡£¡¡
ç¹´â´µ¼Ô187Îã¤Î¸¡Æ¤¤ÇÀè¹Ô2ǯ°ÊÆâ¤ÎÅüÇ¢ÉÂȯ¾É¤¬52.5%¤È¹â¤¤¡£
50ºÐ°Ê¾å¤ÎÅüǢɽéȯ´µ¼Ô2122̾¤ÎÌó1¡ó¤¬3ǯ°ßÆâ¤Ëç¹´â¤ò¹çÊ»¡£¡¡
55ºÐ°Ê¾å¤ÎÅüǢɽéȯ·²¤Ç¡¢·ìÅü¡¢·ìÃæç¹¹ÚÁÇ¡¢
¼ðáç¥Þ¡¼¥«¡¼¡¢US
½ê¸«¤Ç¤¤¤º¤ì¤«¤Î°Û¾ï¤òǧ¤á¤¿»þÅÀ¤Ç
Æâ»ë¶ÀŪµÕ¹ÔÀ繴ɤ±Æ¤ò¹Ô¤Ã¤¿½ê¡¢13.9%¤¬ç¹´â¤È¿ÇÃÇ¡£
CQ1-3¡¡ç¹´â¤òµ¿¤Ã¤¿¾ì¹ç¡¢¤Þ¤º¹Ô¤¦¤Ù¤¸¡ºº¤Ï²¿¤«¡©¡¡1. ·ìÃæç¹¹ÚÁǤÏç¹¼À´µ¿ÇÃǤ˽ÅÍפÀ¤¬¡¢ç¹´â¤ËÆÃ°ÛŪ¤Ç¤Ï¤Ê¤¤¡£¥°¥ì¡¼¥ÉC1
2. CA19-9¤ò´Þ¤à¼ðáç¥Þ¡¼¥«¡¼Â¬Äê¤Ïç¹´â¿ÇÃǤäç¹´â¥Õ¥©¥í¡¼¥¢¥Ã¥×¤Ë´«¤á¤é¤ì¤ë¡Ê¥°¥ì¡¼¥ÉB¡Ë¤¬¡¢Áá´üç¹´â¤Î¸¡½Ð¤Ë¤ÏÍÍѤǤϤʤ¤¡£¥°¥ì¡¼¥ÉC1
3. US¤Ïç¹´â¤ÎºÇ½é¤Î
¥¹¥¯¥ê¡¼¥Ë¥ó¥°¤Ë´«¤á¤é¤ì¤ë¡Ê¥°¥ì¡¼¥É£Â¡Ë¤¬¡¢¸¡¿Ç¤Ç¤Î¸¡½ÐΨ¤ÏÄ㤤¡Ê¥°¥ì¡¼¥ÉC1¡Ë¡£¼ç繴ɤγÈÄ¥¤ä
ǹ˦¤¬ç¹´â¤Î´ÖÀܽ긫¤È¤·¤Æ½ÅÍפǤ¢¤ë¡£¡Ê¥°¥ì¡¼¥ÉB¡Ë¡£¤³¤Î¤è¤¦¤Ê½ê¸«¤¬¤ß¤È¤á¤é¤ì¤¿¾ì¹ç¤Ï¡¢¤¹¤ß¤ä¤«¤Ë
CT¸¡ºº¤ò¤Ï¤¸¤á¤È¤¹¤ë¸¡ºº¤ò¹Ô¤¦¤³¤È¤¬¶¯¤¯´«¤á¤é¤ì¤ë¡£¡Ê¥°¥ì¡¼¥ÉA¡Ë
4. ¾åµ¸¡ºº¤Ç°Û¾ï½ê¸«¤¬Ç§¤á¤é¤ì¤ë¤âç¹´â¤Î³ÎÄê¿ÇÃǤ˻ê¤é¤Ê¤¤¾ì¹ç¤Ë¤Ï¡¢°Ê¸å¤ÎÄê´üŪ¤Ê¸¡ºº¤È¿µ½Å¤Ê·Ð²á´Ñ»¡¤¬´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉB
Ä̾ï¤Î¿¦¾ì¸¡¿Ç¤Ç¤ÎUS¤Ë¤è¤ëç¹²èÁü¤Îͽ긫Ψ¤ÏÌó1%¤Ç¡¢ç¹´âȯ¸«Î¨¤ÏÌó0.06%°Ê²¼¤ÈÄ㤤¡£
CA19-9 70-80%, Span-1 70-80% Dupan-2 50-60%, CEA 30-60%, CA50 60%
繴⸡½Ð¤Ë¤Ä¤Ê¤¬¤ë´ÖÀܽ긫¤È¤·¤Æ¡¢¼ç繴ɤγÈÄ¥¡Ê2mm°Ê²¼¡Ë¤äǹ˦¤¬ç¹´â¤ÎÁ°¶î½ê¸«¡Ê¥ì¥Ù¥ë·¡Ë¤¬¹Í¤¨¤é¤ì¡¢¤³¤Î¤è¤¦¤Ê½ê¸«¤¬¤ß¤é¤ì¤¿¾ì¹ç¤Ï¡¢Â®¤ä¤«¤ËCT¸¡ºº¤ò¤Ï¤¸¤á¤È¤¹¤ë¼¡¤Î¥¹¥Æ¥Ã¥×¤Ø¿ÇÃǤò¿Ê¤á¤ë¤Ù¤¤Ç¤¢¤ë¡£
CQ1-4 ç¹´â¤òµ¿¤Ã¤¿¾ì¹ç¡¢¼¡¤Ë¹Ô¤¦¤Ù¤¸¡ºº¤Ï²¿¤«¡©£±¡¥ ç¹´â¤Î¼£ÎÅÊý¿Ë·èÄê¤Î¤¿¤á¤Ë¤Ï¼ÁŪ¿ÇÃǤ¬É¬¿Ü¤Ç¡¢¹Ô¤¦¤è¤¦¶¯¤¯´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉA
£²¡¥ ç¹´â¤ÏUSµÚ¤ÓCT¡Ê¤±Æ¤¬Ë¾¤Þ¤·¤¤¡Ë¤ò¹Ô¤¤¡¢É¬Íפ˱þ¤¸¤ÆMRCP, EUS, ERP, PET¤òÁȤ߹ç¤ï¤»¤ë¤è¤¦¶¯¤¯´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉA
¡¦2cm°Ê²¼¤ÎÉÂÊѤǤÏ
Ê¢ÉôͲ»ÇȤǴ¶ÅÙ57%, ñ½ãCT¤Ç50%¡£Â¤±ÆCT¤Ç70%Á°¸å¡£
¤½¤Î¾¤Î¸¡ºº¤È¤·¤Æ
¡¦MRCP¤Ï´¶ÅÙ95¡ó¡¢
ÆÃ°ÛÅÙ82%¡¡Àµ¾ï¤Êç¹´ÉÁü¤òÄ褹¤ëç¹´â¤Ï3¡ó̤Ëþ¡£
¡¦EUS¤Ï´¶ÅÙ86-100%,¡¡ÆÃ°ÛÅÙ58.3-97%
¡¦PET¤Ï´¶ÅÙ82-95%(2cm°Ê²¼¤Ç¤Ï68.8¡ó)
CQ1-5 ç¹´â¤Ë¤ª¤±¤ëºÙ˦¿Ç¡¢ÁÈ¿¥¿Ç¤ÎŬ±þ¤È°ÕµÁ¤Ï¡©1. ³Æ¼ï¤Î²èÁü¸¡ºº¤Ë¤è¤êç¹¼ðáî¤Î¼ÁŪ¿ÇÃǤ¬¤Ä¤«¤Ê¤¤¾ÉÎã¤Ç¤Ï¡¢¼£Îų«»Ï¤Ë¤¢¤¿¤êÁÈ¿¥¤â¤·¤¯¤ÏºÙ˦¿Ç¤Ë¤è¤ë³ÎÄê¿ÇÃǤ¬Ë¾¤Þ¤·¤¤¡£³ÎÄê¿ÇÃÇË¡¤È¤·¤ÆÄ¶²»ÇÈ
¥¬¥¤¥É²¼Àü»ÉµÛ°úºÙ˦¿Ç¡¦ÁÈ¿¥¿Ç¡¢ERCP²¼
ç¹±ÕºÙ˦¿Ç¡¢ERCP²¼ÁÈ¿¥¿Ç¤Ê¤É¤¬¤¢¤ê¡¢´µ¼Ô¤È»ÜÀߤξõ¶·¤«¤éŬÀÚ¤ÊÊýË¡¤òÍѤ¤¤ë¡£¥°¥ì¡¼¥ÉB
2. Ͳ»ÇÈÆâ»ë¶À²¼Àü»ÉµÛ°úºÙ˦¿Ç¤Ï
Ê¢ÉôͲ»Çȸ¡ºº¤äCT¤Ê¤É¤Ç¼ðáî¤òª¤¨¤ë¤³¤È¤¬º¤Æñ¤ÊÉÂÊѤËÂФ·¤Æ¤âÍÍѤǤ¢¤ë¡£¥°¥ì¡¼¥ÉC1
3. °äÅÁ»Ò¸¡º÷¤ÏºÙ˦¿Ç¡¦ÁÈ¿¥¿Ç¤ÎÊä½õŪ¿ÇÃǤȤ·¤ÆÍÍѤǤ¢¤ë¡£¥°¥ì¡¼¥ÉC1
Çã¤Ã¤Æ¤ß¤Þ¤¹(^-^)/¤Þ¤æ¤É¤óDQ9 ¤â¤é¤Ã¤¿ÃϿޤβòÀÏ¥À¥¦¥ó¥í¡¼¥É¤·¤¿¤ó¤À¤±¤É¡¢¥í¥Ã¥¯¤¬¤«¤«¤Ã¤Æ¤ë¡¼¼ðáçÀç¹Ç¹Ë¦Âçºå¤Î¤ª¤ä¤¸ÍͤΤ½¤Î¸å£ÁmylaseÍÍ
¤´Ìµº»ÂÁ¤·¤Æ¤ª¤ê¤Þ¤¹¡£Âçºå¤Î¤ª¤ä¤¸ÍÍ¤ÈÆ±¤¸É±¡¤Ç£É£Ð£Í£Î¤ò·Ð²á´Ñ»¡¤·¤Æ¤¤¤ë¤±¤é¤Ç¤¹¡£
¤³¤Á¤é¤Ç¡¢Âçºå¤Î¤ª¤ä¤¸Íͤ¬¥¯¥é¥¹£µ¤¬½Ð¤Æ¤·¤Þ¤Ã¤¿¤³¤È¡£»ä¤ÈƱ¤±¤é¼ðáçÀç¹Ç¹Ë¦SPN¡©AmylaseÍÍ
½é¤á¤Æ¤ªÊؤêÃפ·¤Þ¤¹¡£
º£Ç¯£¹·î¤Î·ò¿Ç¤Ë¤Æ´ÎÃÀ·Ï¹ÚÁǤΰ۾ï¤ò»ØÅ¦¤µ¤ì¡¢Ê¢ÉôUS¤ò¹Ô¤Ã¤¿¤È¤³¤í¡¢ç¹Æ¬Éô¤Ë£³£ã£í¤Îǹ˦ÀÉÂÊѤò»ØÅ¦¤µ¤ì¤Þ¤·¤¿¡£
¤½¤Î¸å¡¢E¤Õ¤¡¡¼¼ðáçÀç¹Ç¹Ë¦¥â¥â¤Ç¤¹AmylaseÍÍ
ÁᮤΤªÊÖ»öÂçÊÑ´¶¼Õ¤¤¤¿¤·¤Þ¤¹¡£
²¿·¿¤Ê¤Î¤«°å»Õ¤Ë³Îǧ¤·¤Þ¤»¤ó¤Ç¤·¤¿¡Ä¡££É£Ð£Í£Î¤â½é¤á¤ÆÊ¹¤¯ÉÂ̾¤Ç¡¢Ã챤¬¤¢¤ê¤Þ¤»¤ó¤Ç¤·¤¿¡£±ÇÁü¤Ï¡¢¤Á¤ç¤¦¤É¤¿¤é¤³¥â¥â¼ðáçÀç¹Ç¹Ë¦¤³¤ó¤Ë¤Á¤Ï¡¢¥â¥â¤µ¤ó¡£70ºÐ¤È¸À¤¦¤Î¤ÏÈó¾ï¤ËÈù̯¤ÊǯÎð¤Ç¤¹¤Í¡£
IPMN¤Ï¼çç¹´É·¿¤Ê¤Î¤Ç¤·¤ç¤¦¤«¡¢¤À¤È¤¹¤ì¤Ð¾ÍèŪ¤Ë°À²½¤¹¤ë²ÄǽÀ¤¬¹â¤¤¤Î¤Ç¡¢Ä̾ï¤Ç¤·¤¿¤é¼ê½ÑŬ±þ¤Çamylase¼ðáçÀç¹Ç¹Ë¦¤è¤í¤·¤±¤ì¤Ð¤´°Õ¸«¤ª´ê¤¤¤·¤Þ¤¹AmylaseÍÍ
Êì¡Ê£·£°ºÍ¡Ë¤¬I£Ð§®£Î¡Ê£µ£ã£í¡Ë¤È¿ÇÃǤµ¤ì¤Þ¤·¤¿¡£
¼ðáç¤ÏÂ礤¤¤Ç¤¹¤¬¡¢ç¹´É¤Ë¿´Çۤʤ¯¡¢ç¹Â¡¤Î¼ðáç¥Þ¡¼¥«¡¼¤â±¢À¤À¤Ã¤¿¤½¤¦¤Ç¤¹¡£¤¿¤À¡¢£³£ã£í°Ê¾å¤Ï°¥â¥âËýÀç¹±ê¤Î¥¹¥Æ¥ó¥È¼£Îťĥ¤¥Ã¥¿¡¼¤Ïµ¤·Ú¤ÇÌÌÇò¤¤¤Ç¤¹¤è¡£µ¤·Ú¤Ë¡÷¤äD¤òÈô¤Ð¤·¤Æ¤¯¤À¤µ¤¤¡£
ç¹±ê¤Ï¾¤Î¼À´µ¤ËÈæ¤Ù¤ÆÊä½õ¤Ï¤Û¤È¤ó¤É¤Ê¤¤¤Ç¤¹¤Í¡£¤¸¤ï¤¸¤ï¿¿ÌʤÇÄù¤á¤é¤ì¤Æ¤¤¤¯¤è¤¦¤Ë´µ¼Ô¤ÏÈèÊÀ¤·amylaseËýÀç¹±ê¤Î¥¹¥Æ¥ó¥È¼£ÎÅÊ¿¶ÑÆþ±¡Æü¿ô¤Ïû¤¯¤ÆÎɤ¤¤Î¤Ç¤¹¤¬¡¢¼£ÎÅÈñ¤Ï¹â¤¤¤Ç¤¹¤Í¡£¤³¤Î¼£ÎŤò¹Ô¤¦½Å¾É¤ÎËýÀ繱괵¼Ô¤Ë¤Ï¸øÈñ½õÀ®¤Ï¤Ê¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©
ÏäÏÊѤï¤ê¤Þ¤¹¤¬¡¢´ÉÍý¿Í¤µ¤ó¤Ë»É·ã¤ò¼õ¤±ma9745Æþ±¡À¸³è¤Ètwitter½Û´Ä´ï¤Ê¤É¤â ¤½¤¥¤Ç¤¹¤±¤É²¿¸Î ÂΤतÉôʬ¤Æ´¨¤µ¤Ë¼å¤¤¤ó¤Ç¤·¤ç¤¦¤Í¡ª´¨¤¯¤ÆÂΤ¬¥¥å¡¼¥Ã¤È½Ì¤³¤Þ¤ë»þ °ì½ï¤Ë·ì´É¤ä¤é¡´ï¤ä¤é¤â½Ì¤³¤Þ¤ëµ¤¤¬¤·¤Á¤ã¤¤¤Þ¤¹¡£
¥Í¥Ã¥È¤¬²ÖǢϩ·ëÀÐÇ¢´É·ëÀⶤâ¤Ê¤ê¤Þ¤·¤¿¡£²¿¤ÎÁ°¿¨¤ì¤â¤Ê¤¯¤¤¤¤Ê¤ê·ãÄË¡Ä
Ìõ²ò¤ê¤Þ¤»¤ó¤Ç¤·¤¿¡£
¤¢¤ÎÄˤߤϤʤ俿ͤ·¤«²ò¤é¤Ê¤¤¤Í¡Äµû Æù ÌîºÚ¤â ÂÌÌܤʤ鿩¤¦¤â¤ó¤Ê¤¤¤ä¤ó¡Ä
²¶¤Ï¿©¤Ùʪ¤ÎÎ̤ϸº¥À¥¤¥ä¥ëËýÀ繱ꡡ¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó ͽ¸åÆÃ°ÛÅÙ¡§ç¹±ê¤òç¹±ê¤À¤È¸«¤Ä¤±¤é¤ì¤ë³ÎΨ¡£
´¶ÅÙ¡§Â¾¤Î¼À´µ¤òç¹±ê¤À¤È´Ö°ã¤ï¤Ê¤¤³ÎΨ¡£
¤È¤¤¤Ã¤¿¡¢´¶¤¸¤Ç¤¹¤Í¡£
»ä¤Ïº£¡¢US¡Ê³°Éô¥¨¥³¡¼¡Ë¤«¤éCT¤Þ¤Ç¥Õ¥ë¥³¡¼¥¹¤Ç¼õamylaseËýÀ繱ꡡ¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó ͽ¸å°å³Ø½ñ¤Ë¤·¤Æ¤Ï°Â¤¤¤Ç¤¹¤Í¡£
Çã¤Ã¤Æ¤ß¤è¤¦¤«¤Ê¡£
ÆÀ°ÕÅ٤ȴ¶Å٤ΰ㤤¤òÁǿͤˤ狼¤ê¤ä¤¹¤¯ÀâÌÀ¤·¤Æ¤¤¤¿¤À¤±¤ë¤È½õ¤«¤ê¤Þ¤¹¡£
£Å£Õ£Ó¤¬°ìÈÖÎɤ¤¤ß¤¿¤¤¤À¤±¤É¡¢
º£²ó¤â£Ã¤¢¤æ¥ª¥ê¥ª¥óºÂήÀ±·²¼¡¤Ï¤Õ¤¿¤´ºÂ¦ÁήÀ±·²¤Ë´üÂԤǤ¹¤Í¡£Ç¯¤Ç°ìÈÖÂ礤ÊήÀ±·²¤Ç¡¢´ü´Ö¤âŤ¯¡¢º£Ç¯¤Ï¿··î¤¢¤¿¤ê¤Ë¶ËÂçÆü¤¬¤¯¤ë¤Î¤Ç¤¿¤¯¤µ¤ó¸«¤é¤ì¤ë¤È»×¤¤¤Þ¤¹¤è¡£amylase¥ª¥ê¥ª¥óºÂήÀ±·²¶õ¤ò¸«¾å¤²¤Æ30ʬ¡ÄÀ±¤Ï¥Á¥é¥Û¥é¸«¤¨¤ë¤±¤É¾¯¤·²â¤ó¤Ç¤ë¤ß¤¿¤¤¤Çº£Ìë¤Ïή¤ìÀ± ¸«¤ì¤Ê¤µ¤½¤¦¤Ç¤¹¡£¤Ç¤â ¤³¤Ê¤¤¤À¤Î¿··î¤Î»þ¤Ë ¤ª´ê¤¤»ö¤·¤¿¤«¤é¡¢Îɤ·¤È¤·¤Þ¤¹o(^-^)o
¥®¥ê¥Á¥¨¥³»ä¤ÎÃæ¤Î¤¢¤Ê¤¿¤Ê¤«¤Ê¤«¤¤¤¤¤Ç¤¹¤è¡£ÆüËܱDzè¤Ç¤³¤¦¤¤¤¦¤Î¤òºî¤ë¤È°Å¤¯¤Æ¥À¥ë¥¤¤À¤±¤Î±Ç²è¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤¤¤Þ¤¹¤±¤É¡¢¥Ï¥ê¥¦¥Ã¥É¤Ïµîǯ¤Î¥Á¥§¥ó¥¸¥ê¥ó¥°¤ä°¦¤ò¤è¤à¤Ò¤È¤Ê¤É¤Î¤è¤¦¤Ë¡¢¤³¤Î¼êamylase¥¨¥ì¥ó¥¿¡¼¥ë¤Ë¿·¥Õ¥ì¥Ð¡¼¤Ä¤¤¤Ë¥¨¥ì¥ó¥¿¡¼¥ë¤Ë¥¹¥Æ¥Ã¥×¥¢¥Ã¥×½ÐÍè¤Þ¤·¤¿¤«¡£(¾Ð)
¥Þ¥ó¥´¡¼¤Ï´Å¤Ã¤¿¤ë¤¯¤Æ¡¢É¾È½¤¬°¤¤¤è¤¦¤Ê¤ó¤Ç¤¹¤±¤É¡¢¤³¤ì¤Ï¿Í¤½¤ì¤¾¤ì¤Ç¤¹¤«¤é¤Í¡£
Á´¼ïÎࣲËܤŤįþ¤Ã¤¿¤ª»îamylase»ä¤ÎÃæ¤Î¤¢¤Ê¤¿¤³¤ì¡ªÀäÂи«¤ë¡ª¤¢¡¢±Ç²è´Û¤Ï¤Ê¤¤¤«¤é¡Ê¾Ð¡Ë¥ì¥ó¥¿¥ë»Ï¤Þ¤Ã¤¿¤é¸«¤ë¤«¤Ê¡£
ͽ¹ð¸«¤¿¤À¤±¤Çµã¤¤½¤¦¤Ë¤Ê¤Ã¤¿¤è¡£
¤ª¥Ð¥«¤Ê±Ç²è¤è¤ê¡¢¤¤¤í¤¤¤í¤È¹Í¤¨¤µ¤»¤é¤ì¤ë¤è¤¦¤Ê¡¢
¤³¤¦¤¤¥È¥í¥í¥¨¥ì¥ó¥¿¡¼¥ë¤Ë¿·¥Õ¥ì¥Ð¡¼¥¨¥ì¥ó²áµîµ»ö¥³¥á¥ó¥È¤¹¤ß¤Þ¤»¤ó¡£
¤µ¤ó¤¶¤óµñÈݤäƤ¤¤¿¤Î¤Ë¤È¤¦¤È¤¦½èÊý¤µ¤ì¤Æ¤·¤Þ¤¤¤Þ¤·¤¿¡£
¡Ö¥Þ¥ó¥´¡¼¤¬¤ª¤¤¤·¤¤¡×¤È¤É¤³¤«¤Çʹ¤¤¤¿µ¤¤¬¤¹¤ë¤È»×¤Ã¤Æ
¥Þ¥ó¥´¡¼¤ò¤ª´ê¤¤¤¢¤æ¼ðáçÀç¹Ç¹Ë¦Re: ¥¿¥¤¥È¥ë¤Ê¤·¤½¤¦¤Ç¤¹¤Í¡¢ç¹´â¤Èç¹ÀÅüǢɤÏÅ·Çé¤Ë¤«¤±¤ë¤Þ¤Ç¤â¤Ê¤¤¤Î¤«¤â¤·¤ì¤Þ¤»¤ó¡£
¤Þ¤¿¡¢Ê¬´ô·¿IPMN¤È¤¤¤¨¤É¡¢Â¿Â¡´ï¤Ëʻȯ¤¹¤ë²ÄǽÀ¤â¤¢¤ê¤Þ¤¹¤·¡¢¸È©½Ñ¤Ç¤Ê¤¯º¬¼£½Ñ¤ò¹Ô¤¨¤ëamylase